Drug recall · August 12, 2015
Absorica recall
Why: Incorrect/Undeclared Excipients: Product contains undeclared FD&C Yellow No. 5 in the capsule shell.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Absorica (isotretinoin) Capsules, 25 mg, Packaged in 3 x 10 Count Blister Cards/Box, Rx Only. Manufactured for: RANBAXY LABORATORIES, INC Jacksonville, FL 32257 USA. NDC: 10631-133-31.
- Lots / codes
Lot #:14H04AA, Expiry: 02/28/2017.
- Quantity
- 9,229 Boxes
- Company
- Ranbaxy Inc., Princeton, NJ
- Distribution
- Nationwide
- Initiated
- June 26, 2015 · Voluntary: Firm initiated
- Classified
- August 6, 2015
- Reported
- August 12, 2015
- Ended
- April 29, 2016
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Absorica
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.